Optimization of the treatment with beta-lactam antibiotics in critically ill patients—guidelines from the French Society of Pharmacology and Therapeutics (Société …

R Guilhaumou, S Benaboud, Y Bennis… - Critical Care, 2019 - Springer
Background Beta-lactam antibiotics (βLA) are the most commonly used antibiotics in the
intensive care unit (ICU). ICU patients present many pathophysiological features that cause …

Rationalizing antimicrobial therapy in the ICU: a narrative review

JF Timsit, M Bassetti, O Cremer, G Daikos… - Intensive care …, 2019 - Springer
The massive consumption of antibiotics in the ICU is responsible for substantial ecological
side effects that promote the dissemination of multidrug-resistant bacteria (MDRB) in this …

Beta-lactam antibiotic therapeutic drug monitoring in critically ill patients: a systematic review and meta-analysis

R Pai Mangalore, A Ashok, SJ Lee… - Clinical Infectious …, 2022 - academic.oup.com
Therapeutic drug monitoring (TDM) of beta-lactam antibiotics is recommended to address
the variability in exposure observed in critical illness. However, the impact of TDM-guided …

Microbiota–gut–brain axis and epilepsy: a review on mechanisms and potential therapeutics

M Ding, Y Lang, H Shu, J Shao, L Cui - Frontiers in Immunology, 2021 - frontiersin.org
The gut–brain axis refers to the bidirectional communication between the gut and brain, and
regulates intestinal homeostasis and the central nervous system via neural networks and …

Clinical pharmacokinetics in kidney disease: fundamental principles

TN Lea-Henry, JE Carland, SL Stocker… - Clinical journal of the …, 2018 - journals.lww.com
Kidney disease is an increasingly common comorbidity that alters the pharmacokinetics of
many drugs. Prescribing to patients with kidney disease requires knowledge about the drug …

[HTML][HTML] Model-informed precision dosing: State of the art and future perspectives

IK Minichmayr, E Dreesen, M Centanni, Z Wang… - Advanced drug delivery …, 2024 - Elsevier
Abstract Model-informed precision dosing (MIPD) stands as a significant development in
personalized medicine to tailor drug dosing to individual patient characteristics. MIPD moves …

Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT)

A Abdulla, A Dijkstra, NGM Hunfeld, H Endeman… - Critical Care, 2020 - Springer
Background Early and appropriate antibiotic dosing is associated with improved clinical
outcomes in critically ill patients, yet target attainment remains a challenge. Traditional …

What antibiotic exposures are required to suppress the emergence of resistance for gram-negative bacteria? A systematic review

CD Sumi, AJ Heffernan, J Lipman, JA Roberts… - Clinical …, 2019 - Springer
Background The rates of antibiotic resistance in Gram-negative bacteria are increasing. One
method to minimize resistance emergence may be optimization of antibiotic dosing …

Expert clinical pharmacological advice may make an antimicrobial TDM program for emerging candidates more clinically useful in tailoring therapy of critically ill …

M Gatti, PG Cojutti, M Bartoletti, T Tonetti, A Bianchini… - Critical Care, 2022 - Springer
Background Therapeutic drug monitoring (TDM) may represent an invaluable tool for
optimizing antimicrobial therapy in septic patients, but extensive use is burdened by barriers …

Setting the beta-lactam therapeutic range for critically ill patients: is there a floor or even a ceiling?

EF Barreto, AJ Webb, GM Pais, AD Rule… - Critical care …, 2021 - journals.lww.com
OBJECTIVES: Beta-lactam antibiotics exhibit high interindividual variability in drug
concentrations in patients with critical illness which led to an interest in the use of …